331 related articles for article (PubMed ID: 25393642)
1. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome.
Tosi F; Di Sarra D; Kaufman JM; Bonin C; Moretta R; Bonora E; Zanolin E; Moghetti P
J Clin Endocrinol Metab; 2015 Feb; 100(2):661-9. PubMed ID: 25393642
[TBL] [Abstract][Full Text] [Related]
2. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.
Di Sarra D; Tosi F; Bonin C; Fiers T; Kaufman JM; Signori C; Zambotti F; Dall'Alda M; Caruso B; Zanolin ME; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2013 Jun; 98(6):2581-8. PubMed ID: 23596136
[TBL] [Abstract][Full Text] [Related]
3. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
[TBL] [Abstract][Full Text] [Related]
4. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
[TBL] [Abstract][Full Text] [Related]
10. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
11. The insulin-resistant phenotype of polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L
Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
[TBL] [Abstract][Full Text] [Related]
12. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
13. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
[TBL] [Abstract][Full Text] [Related]
14. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.
Puder JJ; Varga S; Kraenzlin M; De Geyter C; Keller U; Müller B
J Clin Endocrinol Metab; 2005 Nov; 90(11):6014-21. PubMed ID: 16105965
[TBL] [Abstract][Full Text] [Related]
15. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
16. Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome.
Jędrzejuk D; Laczmański L; Kuliczkowska J; Lenarcik A; Trzmiel-Bira A; Hirnle L; Dorobisz U; Milewicz A; Lwow F; Urbanovych A; Słoka N
Gynecol Endocrinol; 2015 Jan; 31(1):36-9. PubMed ID: 25093427
[TBL] [Abstract][Full Text] [Related]
17. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
[TBL] [Abstract][Full Text] [Related]
18. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
20. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
